Stock Earnings

Question 1

What are Altimmune Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Altimmune Inc has a total asset of $139, Net loss of $-95

Question 2

What are the key financial ratios for ALT?

Accepted Answer

Altimmune Inc's Current ratio is 9.26, has a Net margin is 0, sales per share of $0.

Question 3

How is Altimmune Inc's revenue broken down by segment or geography?

Accepted Answer

Altimmune Inc largest revenue segment is Treatments for Various Diseases and Disorders, and Vaccines, at a revenue of 20,000 in the most earnings release.For geography, United States is the primary market for Altimmune Inc, at a revenue of 20,000.

Question 4

Is Altimmune Inc profitable?

Accepted Answer

no, according to the latest financial statements, Altimmune Inc has a net loss of $-95

Question 5

Does Altimmune Inc have any liabilities?

Accepted Answer

yes, Altimmune Inc has liability of 15

Question 6

How many outstanding shares for Altimmune Inc?

Accepted Answer

Altimmune Inc has a total outstanding shares of 72.35

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	4	8
Revenue Growth (YoY)	--	--	--	-100%	-50%	60%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	20	18	17	15	13
Research & Development	67	82	65	70	74	49
Operating Expenses	90	103	83	87	89	62
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-84	-95	-88	-84	-97	-54
Income Tax Expense	0	0	0	0	0	-5
Net Income	-83	-95	-88	-84	-97	-49
Net Income Growth	-19%	8%	5%	-13%	98%	145%
Shares Outstanding (Diluted)	89.41	71	53.24	46.93	41.28	25.64
Shares Change (YoY)	26%	33%	13%	14%	61%	95%
EPS (Diluted)	-0.93	-1.33	-1.66	-1.81	-2.35	-1.91
EPS Growth	-36%	-19%	-8%	-23%	23%	19%
Free Cash Flow	-66	-79	-75	-62	-90	-34
Free Cash Flow Per Share	-0.73	-1.11	-1.4	-1.32	-2.18	-1.32
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	-2,125%	-675%
Profit Margin	0%	0%	0%	0%	-2,425%	-612.5%
Free Cash Flow Margin	0%	0%	0%	0%	-2,250%	-425%
EBITDA	-90	-103	-83	--	-85	-54
EBITDA Margin	0%	0%	0%	--	-2,125%	-675%
D&A For EBITDA	0	0	0	--	0	0
EBIT	-90	-103	-83	-87	-85	-54
EBIT Margin	0%	0%	0%	0%	-2,125%	-675%
Effective Tax Rate	0%	0%	0%	0%	0%	9.25%

Altimmune Inc (ALT) Price

ALT Stock Price Chart

ALT Income

Follow-Up Questions